Skip to main content

Thank you for visiting You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Chitosan decreases total cholesterol in women: a randomized, double-blind, placebo-controlled trial


Background: Hypercholesterolemia is an important risk factor for cardiovascular disease. Orally administered chitosan binds lipids in the small intestine and reduces their absorption. Chitosan has been shown to decrease serum cholesterol in animal and human studies. This study investigated the effectiveness of chitosan in reducing serum cholesterol without concomitant diet therapy.

Methods: Ninety female volunteers (age 34–70 y) with confirmed mild to moderate hypercholesterolemia were enrolled into the study. They were randomly assigned to receive chitosan (1.2 g per day) or placebo in a double-blind manner. Serum lipids, body weight and adverse events were assessed at baseline and after 28 and 56 days of treatment. Subjects maintained their usual diet and documented the type and gross amount of food consumed.

Results: Eighty-four subjects (41 chitosan, 43 placebo) were included in the analysis. Chitosan significantly (F=3.19, P=0.04) reduced total cholesterol compared to placebo. In a subgroup of subjects with over 60 y of age, chitosan group significantly reduced total and LDL cholesterol (F=4.21, P=0.02, and F=3.46, P=0.04, respectively) compared with placebo. Adverse effects were few; no serious events were reported.

Conclusions: Our results demonstrate that chitosan is safe and effective for lowering cholesterol. However, the effect of chitosan for decreasing cholesterol is mild.

Sponsorship: Shimane Institute of Health Science, Izumo, Japan.

This is a preview of subscription content

Access options

Buy article

Get time limited or full article access on ReadCube.


All prices are NET prices.

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5


  • Arai, J, Tamama, K, Ishiyama, N, Kimura, T, Kuwabara, A, Kanda, T, Fukumura, Y & Kobayashi, I (2000). Contemplation of age-adjusted standard values of lipid profiles in Japan. J. Med., 31, 262–270.

    CAS  PubMed  Google Scholar 

  • Bucher, HC, Griffith, LE & Guyatt, GH (1998). Effect of HMGcoA reductase inhibitors on stroke. A meta-analysis of randomized, controlled trials. Ann. Intern. Med., 128, 89–95.

    CAS  Article  Google Scholar 

  • Colombo, P & Sciutto, AM (1996). Nutritional aspects of chitosan employment in hypocaloric diet. Acta Toxicol. Ther., 17, 278–302.

    Google Scholar 

  • Davidson, MH, Maki, KC, Karp, SK & Ingram, KA (2002). Management of hypercholesterolaemia in postmenopausal women. Drugs Aging, 19, 169–178.

    CAS  Article  Google Scholar 

  • Ebihara, K & Schneeman, BO (1989). Interaction of bile acids, phospholipids, cholesterol and triglyceride with dietary fibers in the small intestine of rats. J. Nutr., 119, 1100–1106.

    CAS  Article  Google Scholar 

  • Gallaher, CM, Munion, J, Hesslink, R Jr, Wise, J & Gallaher, DD (2000). Cholesterol reduction by glucomannan and chitosan is mediated by changes in cholesterol absorption and bile acid and fat excretion in rats. J. Nutr., 130, 2753–2759.

    CAS  Article  Google Scholar 

  • Giustina, A & Ventura, P (1995). Weight-reducing regimens in obese subjects: effects of a new dietary fibre integrator. Acta Toxicol. Ther., 16, 199–214.

    Google Scholar 

  • Kannel, WB (1995). Range of serum cholesterol values in the population developing coronary artery disease. Am. J. Cardiol., 76, 69C–77C.

    CAS  Article  Google Scholar 

  • Lee, AJ & Maddix, DS (2001). Rhabdomyolysis secondary to a drug interaction between simvastatin and clarithromycin. Ann. Pharmacother., 35, 26–31.

    CAS  Article  Google Scholar 

  • Martin, MJ, Hulley, SB, Browner, WS, Kuller, LH & Wentworth, D (1986). Serum cholesterol, blood pressure, and mortality: implications from a cohort of 361,662 men. Lancet, 2, 933–936.

    CAS  Article  Google Scholar 

  • Moghadasian, MH, Mancini, GB & Frohlich, JJ (2000). Pharmacotherapy of hypercholesterolaemia: statins in clinical practice. Expert. Opin. Pharmacother., 1, 683–695.

    CAS  Article  Google Scholar 

  • Muzzarelli, RA, Ilari, P & Petrarulo, M (1994). Solubility and structure of N-carboxymethylchitosan. Int. J. Biol. Macromol., 16, 177–180.

    CAS  Article  Google Scholar 

  • Pekkanen, J, Linn, S, Heiss, G, Suchindran, CM, Leon, A, Rifkind, BM & Tyroler, HA (1990). Ten-year mortality from cardiovascular disease in relation to cholesterol level among men with and without preexisting cardiovascular disease. New Engl. J. Med., 322, 1700–1707.

    CAS  Article  Google Scholar 

  • Pittler, MH, Abbot, NC, Harkness, EF & Ernst, E (1999). Randomized, double-blind trial of chitosan for body weight reduction. Eur. J. Clin. Nutr., 53, 379–381.

    CAS  Article  Google Scholar 

  • Rackley, CE (2002). Strategies for the prevention of atherosclerotic progression in women. Cardiol. Rev., 10, 119–125.

    Article  Google Scholar 

  • Rose, G, Hamilton, PS, Keen, H, Reid, DD, McCartney, P & Jarrett, RJ (1977). Myocardial ischaemia, risk factors and death from coronary heart disease. Lancet, 1, 105–109.

    CAS  Article  Google Scholar 

  • Sacks, FM, Pfeffer, MA, Moye, LA, Rouleau, JL, Rutherford, JD, Cole, TG, Brown, L, Warnica, JW, Arnold, JM, Wun, CC, Davis, BR & Braunwald, B (1996). The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. New Engl. J. Med., 335, 1001–1009.

    CAS  Article  Google Scholar 

  • Sharrett, AR, Ballantyne, CM, Coady, SA, Heiss, G, Sorlie, PD, Catellier, D & Patsch, W (2001). Coronary heart disease prediction from lipoprotein cholesterol levels, triglycerides, lipoprotein(a), apolipoproteins a-i and b, and hdl density subfractions: the atherosclerosis risk in communities (aric) study. Circulation, 104, 1108–1113.

    CAS  Article  Google Scholar 

  • Shepherd, J, Cobbe, SM, Ford, I, Isles, CG, Lorimer, AR, MacFarlane, PW, McKillop, JH & Packard, CJ (1995). Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group. New Engl. J. Med., 333, 1301–1307.

    CAS  Article  Google Scholar 

  • Sheu, WH, Jeng, CY, Young, MS, Le, WJ & Chen, YT (2000). Coronary artery disease risk predicted by insulin resistance, plasma lipids, and hypertension in people without diabetes. Am. J. Med. Sci., 319, 84–88.

    CAS  Article  Google Scholar 

  • Sugano, M, Fujikawa, T, Hiratsuji, Y, Nakashima, K, Fukuda, N & Hasegawa, Y (1980). A novel use of chitosan as a hypocholesterolemic agent in rats. Am. J. Clin. Nutr., 33, 787–793.

    CAS  Article  Google Scholar 

  • Veneroni, G, Veneroni, F, Contos, S, Tripodi, S, de Bernardi, M, Guarino, C & Marleti, AM (1996). Effect of a new chitosan dietary integrator and hypocaloric diet on hyperlipidemia and overweight in obese patients. Acta Toxicol. Ther., 17, 53–70.

    CAS  Google Scholar 

  • Wilson, PW & Kannel, WB (1993). Hypercholesterolemia and Coronary Risk in the Elderly: the Framingham Study. Am. J. Geriatr. Cardiol., 2, 56

    PubMed  Google Scholar 

  • Wuolijoki, E, Hirvela, T & Ylitalo, P (1999). Decrease in serum LDL cholesterol with microcrystalline chitosan. Meth. Find. Exp. Clin. Pharmac., 21, 357–361.

    CAS  Article  Google Scholar 

  • Yihua, YU & Binglin, HE (1997). A new low density lipoprotein (LDL) adsorbent. Artif. Cells Blood Substit. Immobil. Biotechnol., 25, 445–450.

    CAS  Article  Google Scholar 

Download references


The authors thank Kazuo Matsumoto, Access Laboratory for statistical data analysis, Sadaki Kikkawa, More Fresh Co. Ltd, and Chizuko Yamane for assistance with setting up the trial. This work was supported by Medical Research Grants from the Shimane Institute of Health Science.

Author information

Authors and Affiliations


Corresponding author

Correspondence to H Bokura.

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Bokura, H., Kobayashi, S. Chitosan decreases total cholesterol in women: a randomized, double-blind, placebo-controlled trial. Eur J Clin Nutr 57, 721–725 (2003).

Download citation

  • Accepted:

  • Published:

  • Issue Date:

  • DOI:


  • chitosan
  • total cholesterol
  • LDL cholesterol
  • humans
  • females

Further reading


Quick links